ArticleBlood research2022

Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen.

Su-In Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.